High dose versus low dose intravesical interferon-alpha 2b for the treatment of carcinoma in situ of the bladder

This review has been withdrawn.

The reason for withdrawal and previous versions are archived and accessible within the withdrawn record in the Cochrane Library.

Share/Save
Health topics: